about
Crystal Structures of Human Carboxylesterase 1 in Covalent Complexes with the Chemical Warfare Agents Soman and Tabun † , ‡An in vivo zebrafish screen identifies organophosphate antidotes with diverse mechanisms of actionAcute imidazenil treatment after the onset of DFP-induced seizure is more effective and longer lasting than midazolam at preventing seizure activity and brain neuropathology.Antidote use in the critically ill poisoned patient.Neuroprotection Against Diisopropylfluorophosphate in Acute Hippocampal Slices.Predicting outcome in acute organophosphorus poisoning with a poison severity score or the Glasgow coma scale.Changing the Scale and Efficiency of Chemical Warfare Countermeasure Discovery Using the Zebrafish.Protective activity of (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol analogues against diisopropylfluorophosphate neurotoxicity: preliminary structure-activity relationship and pharmacophore modeling.A cembranoid protects acute hippocampal slices against paraoxon neurotoxicityDifferential binding of bispyridinium oxime drugs with acetylcholinesterase.Pro-2-PAM therapy for central and peripheral cholinesterases.Reactivation of human acetylcholinesterase and butyrylcholinesterase inhibited by leptophos-oxon with different oxime reactivators in vitro.Toxicogenomic studies of human neural cells following exposure to organophosphorus chemical warfare nerve agent VX.Effect of acute soman exposure on GABA(A) receptors in rat hippocampal slices and cultured hippocampal neurons.Anticonvulsant discovery through animal models of status epilepticus induced by organophosphorus nerve agents and pesticides.Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study
P2860
Q27644348-24139DD7-4BB8-4AFD-98AC-2D1EAC75D79DQ33740260-80C5D6EC-C437-4AF8-B669-82400EAA8AF7Q34151333-E43A2E3C-A248-4A59-8E37-45B3BE701579Q34562529-E37E66FE-61C7-4118-B955-CF3E2139D254Q36263851-332762DF-FB31-4D18-8150-76E23048140BQ36803784-AAD5E7C7-8AFB-4872-8B81-FFE8C9BF45F0Q37325976-C9C6DAD1-6060-4029-ABA8-F931440AB63FQ37482202-FA455122-8005-40C1-91BE-66834B584F54Q38262535-B9764AF7-9EE2-4123-8032-75DC6FDF18AEQ39013062-3A3E52D1-4AD6-4C1A-8ABA-57CFC9DC0F9DQ41240603-13C37C22-3D57-4FA3-99FF-D1889B857E7CQ41243273-50B73CC5-77BE-4B4B-8C26-6884987129EFQ45902153-5F03F82B-B3BE-4E05-9747-87301AE4F85EQ48257694-6502A22B-7583-420C-B255-D80E845729C1Q53761234-DE896942-DE5F-48DF-97A5-F01E5C6E00C6Q58696400-D9C81FCF-7995-4378-984E-1EE6D5627A39
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Therapy for nerve agent poisoning.
@ast
Therapy for nerve agent poisoning.
@en
type
label
Therapy for nerve agent poisoning.
@ast
Therapy for nerve agent poisoning.
@en
prefLabel
Therapy for nerve agent poisoning.
@ast
Therapy for nerve agent poisoning.
@en
P1433
P1476
Therapy for nerve agent poisoning.
@en
P2093
Jonathan Newmark
P304
P356
10.1001/ARCHNEUR.61.5.649
P577
2004-05-01T00:00:00Z